EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apo10 and TKTL1 in blood macrophages as potential biomarkers for early diagnosis of operable breast cancer

Minqing Wu, Qiyu Huang, Lijuan Zhang, Yuying Liu, Musheng Zeng, Chuanbo Xie

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07569-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Minqing Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen Univ…. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Early Detection of Cancer, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Medical Scientific Research Foundation of Guangdong Province of China, the Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Blood macrophage Apo10 and TKTL1 detection is a novel, noninvasive cancer screening approach, but its relevance in breast cancer remains uncertain. We compared the potential diagnostic value of Apo10 and TKTL1 with commonly used tumor markers in differentiating breast cancer patients.

Methods

Physical examination and blood sample data from breast cancer patients who did not receive surgery or chemotherapy (retrospective; breast cancer group) and those with benign breast nodules and completely healthy subjects (prospective; control group) were collected from October 2020 to July 2022 at Sun Yat-sen University. Descriptive statistics and receiver operating characteristic (ROC) curves were generated. The area under the ROC curve (AUROC) was calculated to compare the diagnostic efficiency of Apo10 and TKTL1 with conventional biomarkers (carcinoembryonic antigen [CEA], cancer antigens [CA-125, CA-199, CA-153]) in differentiating breast cancer from healthy breasts and benign breast nodules.

Results

From October 2020 to July 2022, 153 breast cancer patients (primarily early-stage disease: n = 113 (73.9%) stage I/II) and 153 control participants (benign breast nodules, n = 56; healthy, n = 97) were included in this study. The breast cancer subtypes were mainly invasive ductal carcinoma (92.8%), with a few cases of DCIS (5.9%), infiltrating lobular carcinoma (0.7%), and mucinous carcinoma (0.7%). Notably, Apo10, TKTL1, and Apo10 + TKTL1 (APT) levels were significantly greater in the cancer group than in the control group (P < 0.001), demonstrating high diagnostic value (AUC = 0.901, 0.871, 0.938) that surpassed CA-125, CA-199, CA-153, and CEA. In a subgroup analysis excluding stage III patients, APT-based breast cancer screening was minimally affected, with the AUROC (0.933–0.938) varying by ≤ 1%.

Conclusion

Compared with conventional biomarkers, Apo10, TKTL1, and APT showed superior early-stage breast cancer screening efficacy, potentially emerging as a promising marker for discriminating breast cancer from healthy breasts and nontumoral lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorEarly Detection of CancerMacrophagesHumansFemaleMiddle AgedAdultAgedROC CurveRetrospective StudiesCase-Control StudiesNeoplasm Staging

Stichwörter der Autor:innen

AUROCApo10Breast cancerCA-125CA-153CA-199CEATKTL1

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Cancer Prevention Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Yuexiu District, Guangzho…
  • School of Public Health, Guangxi Medical University, Nanning, 530021, Guangxi, China.
  • Department of Breast Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Yuexiu District, Gua…
  • Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, 651 Dongfengdong Road, Yuexiu Distric…
  • Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Guangzhou, 510060, Guangdong, China. zengmsh@sysucc.org.cn.

Förderung

  • the Medical Scientific Research Foundation of Guangdong Province of China
  • the Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Wu, M., Huang, Q., Zhang, L., Liu, Y., Zeng, M., & Xie, C. (2025). Apo10 and TKTL1 in blood macrophages as potential biomarkers for early diagnosis of operable breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07569-3

Vancouver

Wu M, Huang Q, Zhang L, Liu Y, Zeng M, Xie C. Apo10 and TKTL1 in blood macrophages as potential biomarkers for early diagnosis of operable breast cancer. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07569-3

BibTeX
@article{Wu2025,
  author = {Wu, Minqing and Huang, Qiyu and Zhang, Lijuan and Liu, Yuying and Zeng, Musheng and Xie, Chuanbo},
  title = {Apo10 and TKTL1 in blood macrophages as potential biomarkers for early diagnosis of operable breast cancer},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07569-3}
}
Kostenlos starten →